Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Consensus guidance for prevention and management of nausea and vomiting in patients treated with zolbetuximab + chemotherapy: a RAND/UCLA modified Delphi panel study.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Predictors of overall survival in advanced biliary tract cancer in the phase 3 TOPAZ-1 study.
Journal: Hepatology communications
Published: June 30, 2025
Impact of Race on Admission, Clinical Outcomes, and Disposition in Cholangiocarcinoma: Insights from the National Inpatient Database.
Journal: Diseases (Basel, Switzerland)
Published: June 01, 2025
Immune-mediated adverse events in the randomized phase 3 TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer.
Journal: The oncologist
Published: November 26, 2024
An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202.
Journal: ESMO open
Published: January 31, 2024
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Journal: JCO precision oncology
Published: December 01, 2023
Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma.
Journal: Cancer medicine
Published: December 28, 2022
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 13, 2022
Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma.
Journal: Journal for immunotherapy of cancer
Published: December 07, 2022
Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial.
Journal: The Lancet. Oncology
Published: April 06, 2022
A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer.
Journal: Annals of surgery
Published: February 25, 2021
Last Updated: 09/26/2026